1. Maurice DM. The location of the fluid pump in the cornea.
J Physiol 1972;221:43-54.
2. Murphy C, Alvarado J, Juster R, et al. Prenatal and postnatal cellularity of the human corneal endothelium. A quantitative histologic study. Invest Ophthalmol Vis Sci 1984;25:312-322.
3. Bourne WM, Nelson LR, Hodge DO. Central corneal endothelial cell changes over a ten-year period. Invest Ophthalmol Vis Sci 1997;38:779-782.
4. Bourne WM. Cellular changes in transplanted human corneas.
Cornea 2001;20:560-569.
5. Bourne WM, Kaufman HE. Specular microscopy of human corneal endothelium in vivo. Am J Ophthalmol 1976;81:319-323.
6. Waring GO 3rd, Bourne WM, Edelhauser HF, et al. The corneal endothelium. Normal and pathologic structure and function. Ophthalmology 1982;89:531-590.
7. Alvarado JA, Gospodarowicz D, Greeburg G. Corneal endothelial replacement. In vitro formatin of an endothelial monolayer. Invest Ophthalmol Vis Sci 1981;21:300-316.
8. Gospodarowicz D, Greenburg G. The coating of bovine and rabbit corneas denuded of their endothelium with bovine corneal endothelial cells. Exp Eye Res 1979;28:249-265.
9. Gospodarowicz D, Greenburg G, Alvarado J. Transplantation of cultured bovine corneal endothelium on rabbit cornea: clinical implication for human studies. Proc Natl Acad Sci 1979;76:464
10. Gospodarowicz D, Greenburg G, Alvarado J. Transplantation of cultured bovine corneal endothelium to species with nonregenerative endothelium. Arch Ophthalmol 1979;97:2163-2169.
11. Insler MS, Lopez JG. Extended incubation times improves corneal endothelial cell transplantation success. Invest Ophthalmol Vis Sci 1991;32:1828-1836.
12. Joyce NC, Meklir B, Neufeld AH. In vitro pharmacologic separation of corneal endothelial migration and spreading responses. Invest Ophthalmol Vis Sci 1990;31:1816-1826.
13. Jumblatt MM, Maurice DM, McCulley JP. Transplantation of tissue-cultured corneal endothelium. Invest Ophthalmol Vis Sci 1978;17:1135-1141.
14. Maurice DM, McCully JP, Perlmn MM. Development in use of cultured endothelium in corneal transplantation. Doc Ophthalmol Proc Ser 1979;20:151-153.
15. McCulley JP, Maurice DM, Schwartz BD. Corneal endothelial transplantation. Ophthalmology 1980;87:194-201.
16. Schwartz BD, McCully JP. Morphology of transplanted corneal endothelium derived from tissue culture. Invest Ophthalmol Vis Sci 1981;20:467-480.
17. Hadlock T, Singh S, Vacanti JP, et al. Ocular cell monolayers cultured on biodegradable substrates. Tissue Engng 1999;5:187-196.
18. Joo CK, Gree WR, Pepose JS, et al. Repopulation of denude murine Descement's membrane with life-extended murine corneal endothelial cells as a model for corneal transplantation. Graefe's Arch Clin Exp Ophthalmol 2000;238:174-180.
19. Engelmann K, Bednarz J, Valtink M. Prospects for endothelial transplantation. Exp Eye Res 2004;78:573-578.
20. Steinberg ML, Defendi V. Transformation and immortalization of human keratinocytes by SV40. J Invest Dermatol 1983;81:131S-136S.
21. Chang LS, Pan S, Pater MM, et al. Differential requirement for SV40 early genes in immortalization and transformation of primary rat and human embryonic cells. Virology 1985;146:246-261.
22. Wilson SE, Lloyd SA, He YG, et al. Extended life of human corneal endothelial cells transfected with the SV40 large T antigen.
Invest Ophthalmol Vis Sci 1993;34:2112-2123.
23. Strauss M, Griffin BE. Cellular immortalization-an essential step or merely a risk factor in DNA virus-induced transformation? Cancer Cells 1990;2:360-365.
24. Wilson SE, Weng J, Blair S, et al. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci 1995;36:32-40.
25. Fehrmann F, Laimins LA. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003;22:5201-5207.
26. Shin JS, Jang IK, Kim CH, et al. Development and characterization of a rabbit corneal endothelial cell line. Jpn J Ophthalmol 2004;48:454-459.
27. Wilson SE, Weng J, Blair S, et al. Expression of E6/E7 or SV40 large T antigen-coding oncogenes in human corneal endothelial cells indicates regulated high-proliferative capacity. Invest Ophthalmol Vis Sci 1995;36:32-40.
28. He YG, Weng J, Li Q, et al. Fuch's corneal endothelial cells transduced with the human papilloma virus E6/E7 oncogenes. Exp Eye Res 1997;65:135-142.
29. Fehrmann F, Laimins LA. Human papillomaviruses: targeting differentiating epithelial cells for malignant transformation. Oncogene 2003;22:5201-5207.
30. Vousden KH. Interactions between papillomavirus proteins and tumor suppressor gene products. Adv Cancer Res 1994;64:1-24.
31. Bedell MA, Jones KH, Grossman SR, et al. Identification of human papillomavirus type 18 transforming genes in immortalized and primary cells. J Virol 1989;63:1247-1255.
32. Halbert CL, Demers GW, Galloway DA. The E7 gene of human papillomavirus type 16 is sufficient for immortalization of human epithelial cells. J Virol 1991;65:473-478.
33. Cole ST, Danos O. Nucleotide sequence and comparative analysis of the human papillomavirus type 18 genome. Phylogeny of papillomaviruses and repeated structure of the E6 and E7 gene products. J Mol Biol 1987;193:599-608.
34. Wigham CG, Turner HC, Swan J, et al. Modulation of corneal endothelial hydration control mechanisms by Rolipram. Pflugers Arch 2000;440:866-870.